In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Turning Point nets $178mm in initial public offering

Executive Summary

Turning Point Therapeutics Inc. (oncology) netted $178mm through its initial public offering of 10.64mm common shares (including the overallotment) at $18. The company had originally filed to sell 7.35mm shares at a range of $16-18.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies